| Abstrakt: |
A recent study conducted at Debre Tabor University in Ethiopia examined the level of adherence to option B+antiretroviral therapy medication among HIV-positive women breastfeeding for up to 18 months. The research found that only 62.8% of participants adhered to the medication, below the recommended level of over 95%. Factors such as the type of health facility, partner support involvement, and travel time to the facility were significantly associated with adherence to the medication. Partner support was highlighted as crucial for improving adherence. [Extracted from the article] |
